Breast cancer proliferative activity: Is it the source of serum free DNA?Footnote

Available online 13 April 2013

Footnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

References

• Z.H.HuangL.H.LiD.HuaQuantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patientsCancer Lett24320066470
   PubMed Web of Science ®Google Scholar
• M.StrounP.AnkerP.MauriceJ.LyauteyC.LederreyM.BeljanskiNeoplastic characteristics of the DNA found in the plasma of cancer patientsOncology461989318322
   PubMed Web of Science ®Google Scholar
• R.E.C.CabralJ.B.C.NetoM.G.C.CarvalhoCirculating DNA as a biomarker for early detection of cancer: a brief update with an emphasis on lung cancerOpen Lung Cancer J320103844
   Google Scholar
• P.J.PretoriusThe origin of circulating free DNAClin Chem53200722152224
   Web of Science ®Google Scholar
• L.RydlanderE.ZieglerT.BergmanE.SchöberlG.SteinerA.C.BergmanMolecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18Eur J Biochem2411996309314
   PubMedGoogle Scholar
• B.BjorklundR.EinarssonTPS (tissue polypeptide specific antigen) in oncologic practice: a review with reference to 3000 cases of breast cancerTumordiagn Ther1719966773
   Web of Science ®Google Scholar
• R.D’AlessandroM.RoselliP.FerroniS.MariottiA.SpilaS.AloeSerum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA15-3 in the management of breast cancerBreast Cancer Res Treat682001919
   Web of Science ®Google Scholar
• M.J.DuffySerum tumor markers in breast cancer: are they of clinical value?Clin Chem522006345351
   PubMed Web of Science ®Google Scholar
• A.K.PathakM.BhutaniS.KumarA.MohanR.GuleriaCirculating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic toolClin Chem52200618331842
   PubMed Web of Science ®Google Scholar
• G.SozziD.ConteM.LeonR.CiricioneL.RozC.RatcliffeQuantification of free circulating DNA as a diagnostic marker in lung cancerJ Clin Oncol21200339023908
   PubMed Web of Science ®Google Scholar
• G.SozziD.ConteL.MarianiS.Lo VulloL.RozC.LombardoAnalysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patientsCancer Res61200146754678
   PubMed Web of Science ®Google Scholar
• Rintoul RF. Operations on the breast. In: Farquhaerison’s text book of operative surgery. 7th ed. Churchill living stone (pub.); 1986, pp. 270–281.
   Google Scholar
• C.M.HaskellB.B.LowitzA.D.CasciatoBreast cancerA.D.CasciatoB.B.LowitzManual of clinical oncology2nd ed.1985Little and Brown Company (pub.)Boston, Toronto pp. 150–65
   Google Scholar
• M.D.AbeloffA.S.LichterJ.E.NiederhuberL.J.PierceD.C.AzizBreastM.D.AbeloffJ.O.ArmitageA.S.LicherJ.E.NiederhuberClinical Oncology1995Churchil livingstone Inc. (Pub.) Chapter 73, pp 1617–714.
   Google Scholar
• R.GonzalezJ.M.SilvaA.SanchezG.DominguezJ.M.GarciaX.Q.ChenMicrosatellite alterations and TP53 mutations in plasma DNA of small cell lung cancer patients: follow-up study and prognostic significanceAnn Oncol11200010971104
   PubMed Web of Science ®Google Scholar
• J.A.ShawB.M.SmithT.WalshS.JohnsonL.PrimroseM.J.SladeMicrosatellite alterations plasma DNA of primary breast cancer patientsClin Cancer Res6200011191124
   PubMed Web of Science ®Google Scholar
• M.Beau-FallerM.P.GaubA.SchneiderX.DucrocqG.MassardB.GasserPlasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patientsInt J Cancer1052003361370
   PubMed Web of Science ®Google Scholar
• S.GalC.FidlerY.M.D.LoM.TaylorC.HanJ.MooreQuantitation of circulating DNA in the serum of breast cancer patients by real-time PCRBr J Cancer90200412111215
   PubMed Web of Science ®Google Scholar
• S.K.KassimH.FawzyM.M.El RassadF.K.KhalilA.KhalifaTelomerase activity and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patientsClin Biochem342001499504
   Web of Science ®Google Scholar
• N.SamyH.M.RagabN.A.El MaksoudM.ShaalanPrognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-upCancer Biomarkers620106372
   PubMed Web of Science ®Google Scholar
• E.VizcarraA.LluchR.CibriánF.JarqueV.AlberolaV.BellochValue of CA 15.3 in breast cancer and comparison with CEA and TPA: a study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasisBreast Cancer Res Treat371996209216
   Web of Science ®Google Scholar
• X.C.HuW.DayB.JonesW.T.LooL.W.ChowComparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patientsAnticancer Res22200218651868
   Web of Science ®Google Scholar
• Y.ZhengY.ChenM.HuY.LinY.ChenCorrelation of preoperative serum tumor markers with clinicopathological features and prognosis in breast cancerCancer Clin Oncol12012124132
   Google Scholar
• J.M.SilvaJ.SilvaA.SanchezJ.M.GarciaG.DominguezM.ProvencioTumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease- free survivalClin Cancer Res8200237613766
   PubMed Web of Science ®Google Scholar
• B.W.ParkJ.W.OhJ.H.KimS.H.ParkK.KimJ.H.KimPreoperative CA 15–3 and CEA serum levels as predictor for breast cancer outcomesAnn Oncol192008675681
   PubMed Web of Science ®Google Scholar